Efficacy and safety of gemigliptin/metformin initial combination therapy versus either as monotherapy in drug-naive patients with type 2 diabetes

被引：0
|
作者：
Lim, S. [1 ]
Min, K. [2 ]
Yu, J. -M. [3 ]
Chamnan, P. [4 ]
Kim, E. [5 ,13 ]
Yoon, K. -H. [6 ]
Kwon, S. [7 ]
Moon, M. [8 ]
Lee, K. [9 ]
Kim, D. -J. [10 ]
Kim, M. [11 ]
Wongtanate, M. [12 ]
Kim, E. [5 ,13 ]
Kim, S. -H. [13 ]
Lee, M. -K. [14 ]
机构：
[1] Seoul Natl Univ, Bundang Hosp, Songnam, South Korea
[2] Eulji Univ, Med Ctr, Seoul, South Korea
[3] Kangnam Sacred Heart Hosp, Seoul, South Korea
[4] Sunpasitthiprasong Hosp, Ubon Ratchathani, Thailand
[5] Ulsan Univ Hosp, Ulsan, South Korea
[6] Catholic Univ Korea, Seoul St Marys Hosp, Seoul, South Korea
[7] Samsung Changwon Hosp, Chang Won, South Korea
[8] Seoul Natl Univ, Boramae Med Ctr, Seoul, South Korea
[9] Ajou Univ Hosp, Suwon, South Korea
[10] Inje Univ, Ilsan Paik Hosp, Goyang, South Korea
[11] Inje Univ, Haeundae Paik Hosp, Busan, South Korea
[12] Nan Hosp, Nan, Thailand
[13] LG Life Sci, Seoul, South Korea
[14] Sungkyunkwan Univ, Samsung Med Ctr, Seoul, South Korea
来源：
DIABETOLOGIA | 2015年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
109
引用
收藏
页码：S54 / S54
页数：1
相关论文
共 50 条
  • [21] Empagliflozin monotherapy in drug-naive patients with Type 2 diabetes
    Roden, M.
    Weng, J.
    Merker, L.
    Christiansen, A. Vedel
    Roux, F.
    Salsali, A.
    Kim, G.
    Stella, P.
    Woerle, H. J.
    Broedl, U. C.
    DIABETIC MEDICINE, 2015, 32 : 89 - 89
  • [22] Efficacy and safety of linagliptine in combination with metformin in patients with type 2 diabetes uncontrolled on metformin monotherapy
    Taskinen, M. -R.
    Rosenstock, J.
    Tamminen, I.
    Kubiak, R.
    Patel, S.
    Dugi, K. A.
    Tocque-le Goussee, E.
    Woerle, H. -J.
    DIABETES & METABOLISM, 2011, 37 : A107 - A108
  • [23] Efficacy and safety of sitagliptin and the fixed-dose combination of sitagliptin and metformin vs. pioglitazone in drug-naive patients with type 2 diabetes
    Perez-Monteverde, A.
    Seck, T.
    Xu, L.
    Lee, M. A.
    Sisk, C. M.
    Williams-Herman, D. E.
    Engel, S. S.
    Kaufman, K. D.
    Goldstein, B. J.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2011, 65 (09) : 930 - 938
  • [24] Efficacy and Safety of Gosogliptin as Monotherapy and in Combination with Metformin in Patients with Type 2 Diabetes Mellitus
    Trakhtenberg, Julia
    Vostokova, Natalia
    Karavaeva, Oksana
    Kreminskaya, Vera
    Ametov, Alexander
    DIABETES, 2015, 64 : A329 - A330
  • [25] Efficacy and tolerability of initial combination therapy with nateglinide and metformin in treatment-naive patients with type 2 diabetes
    Horton, ES
    Foley, JE
    Shen, SG
    Baron, MA
    CURRENT MEDICAL RESEARCH AND OPINION, 2004, 20 (06) : 883 - 889
  • [26] Efficacy of vildagliptin in drug-naive patients with type 2 diabetes
    Dejager, S.
    Baron, M. A.
    Razac, S.
    Foley, J. E.
    Dickinson, S.
    Schweizer, A.
    DIABETOLOGIA, 2006, 49 : 479 - 480
  • [27] The Safety and Tolerability of Metformin plus Colesevelam in Drug-Naive Patients with Early Type 2 Diabetes Mellitus
    Abby, Stacey L.
    Garvey, W. Timothy
    Handelsman, Yehuda
    Fonseca, Vivian A.
    Goldberg, Ronald B.
    Rosenstock, Julio
    Jones, Michael R.
    Markiewicz, Magdalena
    Jin, Xiaoping
    Misir, Soamnauth
    Nagendran, Sukumar
    DIABETES, 2010, 59 : A173 - A173
  • [28] Effects of Rosiglitazone/Metformin Fixed-Dose Combination Therapy and Metformin Monotherapy on Serum Vaspin, Adiponectin and IL-6 Levels in Drug-Naive Patients with Type 2 Diabetes
    Kadoglou, N. P. E.
    Kapelouzou, A.
    Tsanikidis, H.
    Vitta, I.
    Liapis, C. D.
    Sailer, N.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2011, 119 (02) : 63 - 68
  • [29] The Efficacy of Teneligliptin with Metformin in Drug-Naive Type 2 Subjects
    Chudasama, Dipak B.
    Saboo, Banshi D.
    Panchal, Dharmendra
    Patel, Feny
    Saiyed, Mahira
    Hasnani, Dhruvi
    Chavda, Vipul
    Chandarana, Hardik
    Goklani, Rutul
    DIABETES, 2018, 67
  • [30] Initial treatment with rosiglitazone/metformin fixed-dose combination therapy compared with monotherapy with either rosiglitazone or metformin in patients with uncontrolled type 2 diabetes
    Rosenstock, J.
    Rood, J.
    Cobitz, A.
    Biswas, N.
    Chou, H.
    Garber, A.
    DIABETES OBESITY & METABOLISM, 2006, 8 (06): : 650 - 660
12345